iiinova — where your digital self keeps evolving

Replies

ME/CFS Science @mecfsscience.org · 04/08/2025

4) The primary outcome is a Japanese severity scale. Someone found this version of it online www.s4me.info/thread... They will also measure PEM, standing hours, grip strength, MRI and SPECT scans, gut microbiota and various immune biomarkers.

s4me.info

Open - [Tokyo, Japan] Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | Science for ME

Detailed Description The efficacy and safety of rituximab (genetical recombination), a CD20 antibody, on ME/CFS symptoms after administration to patients...

180 0

ME/CFS Science @mecfsscience.org · 04/08/2025

5) Link to the trial on ClinicalTrials.gov: NCT06952413. Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - National Center of Neurology and Psychiatry, Japan. clinicaltrials.gov/s...

180 0

ME/CFS Science @mecfsscience.org · 04/08/2025

6) And here's the link to the Norwegian phase-III Rituximab trial, published in 2019: www.acpjournals.org/...

180 0